Document is current
Any future updates will be listed below
-
Authors
Le, Hortense
Coudray, Nicolas
Yeaton, Anna
Ramaswami, Sitharam
Karimkhan, Afreen
Cheng, Wei-Yi
Cai, James
Yang, Tai-Hsien Ou
Punekar, Salman R.
Chiriboga, Luis
Velcheti, Vamsidhar
Wong, Kwok-Kin
Sterman, Daniel H.
Moreira, Andre L.
Pass, Harvey I.
Tsirigos, Aristotelis
-
Funding
Funding for this research was provided by:
Roche Access to Distinguished Scientists (ROADS) Programme
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 21 August 2025
First Online: 2 October 2025
Declarations
:
: The authors declare the following competing interests: Aristotelis Tsirigos is a co-founder of Imagenomix; Nicolas Coudray is a scientific advisor for Imagenomix; James Cai, Wei-Yi Cheng, and Tai-Hsien Ou Yang were Roche employees at the time of the study. Wei-Yi Cheng is currently an employee and shareholder of Regeneron Pharmaceuticals Inc. The other authors declare that they have no competing interests.
: Due to privacy and ethical considerations, as well as institutional policies, requests for whole slide images and corresponding clinical information from the additional New York University cohorts should be directed to the corresponding author. Access will require a data transfer agreement between institutions, with the length and conditions determined by the parties following the procedure outlined at . This study was approved by the Institutional Review Board (IRB) at New York University (approved protocol s18-01510).
